Upper gastrointestinal bleeding after hip and knee arthroplasty.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16539204.
- Also identified by DOI 10.3928/01477447-20060301-17.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants increases the risk of upper gastrointestinal bleeding. This article assesses its incidence in patients undergoing hip and knee arthroplasty. A single-center, retrospective study was conducted on 100 consecutive hip and 100 consecutive knee arthroplasties performed at the Victoria Infirmary, Glasgow, between 1998 and 2000. Sixty-three percent of patients were women with a mean age of 74. Fifty-four percent of patients received NSAIDs and all patients received anticoagulants perioperatively. Four and a half percent of patients had upper gastrointestinal bleeding postoperatively. We believe that the incidence of upper gastrointestinal bleeding as a complication is underestimated and recommend gastro-protective agents in the perioperative period for patients on NSAIDs.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Gastrointestinal Hemorrhage
- Postoperative Complications
Anatomy
- hip
- knee